A

ASSTON PHARMACEUTICALS LIMITED

APL
Market snapshot · 2026-08-11 07:15 UTC

$80.00

+$0.31 (+0.39%)

MARKET CAP

STOCK P/E

16.3x

52W HIGH

$105.05

52W LOW

$64.24

BOOK VALUE

$43.72

EPS

$4.92

ROE

SECTOR

Health Care

DEBT/EQUITY

VOLUME

6,000

P/B RATIO

1.83x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹105.05₹94.85₹84.65₹74.44₹64.24VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 3.6% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.47). Confidence: 85%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Undervalued

5Y Average

16.84

Current

16.26

Overvalued

18.35

Undervalued

15.85

P/S
Undervalued

5Y Average

2.77

Current

2.67

Overvalued

3.18

Undervalued

2.35

P/B
Strongly Undervalued

5Y Average

2.56

Current

1.83

Overvalued

1.87

Undervalued

1.75

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹10 CrMar 2026

Latest net profit

₹0.48 CrMar 2026

Latest EPS

₹0.56Mar 2026

Net margin

-27.9%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-40.0%-20.0%0.0%20.0%40.0%0.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr₹0₹1₹2₹2₹3
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit-4.00 Cr0.00 Cr4.00 Cr8.00 Cr12 Cr

Latest reported period: Mar 2026

Results

MetricSep 2024Mar 2025Sep 2025Mar 2026
Sales +15.979.0715.4210.05
Expenses +13.715.8913.1912.85
Operating Profit2.263.182.23-2.80
OPM %14.15%35.06%14.46%-27.86%
Other Income +0.64-0.07-1.864.63
Interest0.420.530.280.36
Depreciation0.020.020.070.25
Profit before tax2.462.560.021.22
Tax %22.76%23.44%-50.00%59.84%
Net Profit +1.901.950.030.48
EPS in Rs24.243.110.040.56
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Loading shareholding pattern...

Events Timeline

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Aug 03, 2026PDFCompany Reports Open

Shareholder Meeting / Postal Ballot-Outcome of EGM

Jul 31, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 14, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

Jul 10, 2026PDFCompany Reports Open

Notice Of Second Extraordinary General Meeting For F.Y. 2026-27 Scheduled To Be Held On 31St July, 2026 At 12:30 PM

Jul 09, 2026PDFCompany Reports Open